ZA972722B - Method for prevention and treatment of viral infectious diseases. - Google Patents

Method for prevention and treatment of viral infectious diseases.

Info

Publication number
ZA972722B
ZA972722B ZA9702722A ZA972722A ZA972722B ZA 972722 B ZA972722 B ZA 972722B ZA 9702722 A ZA9702722 A ZA 9702722A ZA 972722 A ZA972722 A ZA 972722A ZA 972722 B ZA972722 B ZA 972722B
Authority
ZA
South Africa
Prior art keywords
prevention
treatment
infectious diseases
viral infectious
viral
Prior art date
Application number
ZA9702722A
Other languages
English (en)
Inventor
Yoichi Fujii
Toshio Asano
Akio Adachi
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Publication of ZA972722B publication Critical patent/ZA972722B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9702722A 1996-04-10 1997-03-27 Method for prevention and treatment of viral infectious diseases. ZA972722B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8823396 1996-04-10

Publications (1)

Publication Number Publication Date
ZA972722B true ZA972722B (en) 1997-10-23

Family

ID=13937158

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702722A ZA972722B (en) 1996-04-10 1997-03-27 Method for prevention and treatment of viral infectious diseases.

Country Status (9)

Country Link
US (1) US5733904A (id)
EP (1) EP0914824A4 (id)
KR (1) KR100294836B1 (id)
CN (1) CN1215334A (id)
AU (1) AU2177697A (id)
CA (1) CA2248794C (id)
ID (1) ID16598A (id)
WO (1) WO1997037661A1 (id)
ZA (1) ZA972722B (id)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074545A4 (en) * 1998-04-23 2001-08-22 Hiroyoshi Hidaka ISOCHINOLINE SULPHONAMIDE DERIVATIVES AND MEDICINES CONTAINING IT AS AN ACTIVE INGREDIENT
CA2334120C (en) * 1998-08-10 2006-10-17 Asahi Kasei Kogyo Kabushiki Kaisha Oral sustained-release preparation of fasudil hydrochloride
EP1064944A1 (en) * 1999-06-25 2001-01-03 Schering Aktiengesellschaft Protein kinase N inhibitor comprising Fasudil
US6613507B1 (en) 2000-03-21 2003-09-02 Yu-an Chang Boraadamantane compounds for the treatment of pathogenic viruses and other medical applications
CA2443918C (en) * 2001-04-11 2012-06-05 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents containing rho kinase inhibitors
WO2004105757A2 (en) * 2003-05-29 2004-12-09 Schering Aktiengesellschaft Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
KR101194123B1 (ko) * 2004-03-16 2012-10-24 아사히 가세이 파마 가부시키가이샤 패수딜 함유 제제 및 그 안정성을 개선하는 방법
CN100367967C (zh) * 2005-12-12 2008-02-13 天津红日药业股份有限公司 一种盐酸法舒地尔口服制剂
CN102008433A (zh) * 2010-12-01 2011-04-13 广东三信药业有限公司 一种改善稳定性的法舒地尔盐注射液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
JP2720348B2 (ja) * 1989-03-30 1998-03-04 旭化成工業株式会社 脳細胞機能障害改善剤
JPH02273610A (ja) * 1989-04-17 1990-11-08 Chugai Pharmaceut Co Ltd 発毛促進剤
JP3408546B2 (ja) * 1991-02-19 2003-05-19 旭化成株式会社 抗喘息剤
US6429208B1 (en) * 1992-03-27 2002-08-06 Regents Of The University Of California Methods and compositions for restoring impaired cellular immune function
JP2893029B2 (ja) * 1992-08-10 1999-05-17 旭化成工業株式会社 心臓保護剤
JPH0680569A (ja) * 1992-09-03 1994-03-22 Asahi Chem Ind Co Ltd 血小板凝集阻害剤
JP3464012B2 (ja) * 1993-04-05 2003-11-05 旭化成株式会社 精神症候治療剤
JPH0741424A (ja) * 1993-07-28 1995-02-10 Asahi Chem Ind Co Ltd 抗炎症剤
JPH07277979A (ja) * 1994-04-12 1995-10-24 Asahi Chem Ind Co Ltd 過粘性症候群治療または予防剤

Also Published As

Publication number Publication date
EP0914824A1 (en) 1999-05-12
KR19990087673A (ko) 1999-12-27
US5733904A (en) 1998-03-31
CA2248794C (en) 2004-05-04
CA2248794A1 (en) 1997-10-16
EP0914824A4 (en) 2003-04-23
WO1997037661A1 (en) 1997-10-16
ID16598A (id) 1997-10-16
CN1215334A (zh) 1999-04-28
KR100294836B1 (ko) 2001-08-07
AU2177697A (en) 1997-10-29

Similar Documents

Publication Publication Date Title
EP1109580A4 (en) METHOD FOR TREATING OR PREVENTING VIRAL INFECTIONS AND RELATED DISEASES
EP1115286A4 (en) METHOD FOR TREATING AND PREVENTING VIRAL INFECTIONS AND DISEASES RELATED TO THEM
HUP9902055A3 (en) Medical composition for the treatment of herpes simplex virus and other infectious diseases
GB9609932D0 (en) Use of IL-12 and IFN alpha for the treatment of infectious diseases
HU9602310D0 (en) Urease-based vaccine and treatment for helicobacter infection
ZA977564B (en) Method of treatment
EP0758242A4 (en) COMPOSITIONS AND METHODS FOR TREATING CYTOMEGALOVIRUS (CMV) INFECTIONS
EP0783273A4 (en) IMPROVED LASER SYSTEM FOR MEDICAL USE, AND USE THEREOF
EP0610444A4 (en) METHOD OF TREATING VIRAL DISEASES.
AU1733697A (en) Method of purifying and removing viruses
GB9709360D0 (en) Methods for the treatment of herpes virus infections
IL141211A0 (en) Prevention and treatment of viral disease
ZA979731B (en) Treatment of asthma.
AU7297998A (en) Bariatric treatment system and relating methods
AU1556497A (en) Agents for the treatment and prevention of aids
EP0933803A4 (en) PLASMA TREATMENT METHOD
ZA972722B (en) Method for prevention and treatment of viral infectious diseases.
EP0921803A4 (en) METHOD FOR PREVENTING AND TREATING PESTVIRUS INFECTIONS AND RELATED DISEASES
AU5610198A (en) Compounds and methods for treating and preventing bacterial and viral disease
AU4602897A (en) Method for treatment of immunodeficiency virus infection
ZA9510108B (en) Composition and method for prevention and treatment of HIV-1 infection
AU4229197A (en) Treatment of equine protozoal myeloencephalitis
AU5425098A (en) Compounds and methods to treat infectious diseases
AU3530395A (en) Treatment of viral infections
ZA977867B (en) Method of treatment.